[1] |
BALJER BC, KOLHE S, CHAN CD, et al. Advances in image enhancement for sarcoma surgery[J]. Cancer Lett, 2020, 483: 1-11. DOI: 10.1016/j.canlet.2020.03.029.
|
[2] |
MEIRELLES JÚNIOR RF, SALVALAGGIO P, REZENDE MB, et al. Liver transplantation: history, outcomes and perspectives[J]. Einstein (Sao Paulo), 2015, 13(1): 149-152. DOI: 10.1590/S1679-45082015RW3164.
|
[3] |
COOPER D, WIJKSTROM M, HARIHARAN S, et al. Selection of patients for initial clinical trials of solid organ xenotransplantation[J]. Transplantation, 2017, 101(7): 1551-1558. DOI: 10.1097/TP.0000000000001582.
|
[4] |
ZHANG X, LI X, YANG Z, et al. A review of pig liver xenotransplantation: Current problems and recent progress[J]. Xenotransplantation, 2019, 26(3): e12497. DOI: 10.1111/xen.12497.
|
[5] |
van der Heyde MN. Liver transplantation[J]. Ned Tijdschr Geneeskd, 1968, 112(41): 1823-1827.
|
[6] |
WOLF P, MEYER C, BOUDJEMA K, et al. The pig as a model in liver xenotransplantation[J]. Vet Res, 1997, 28(3): 217-222.
|
[7] |
EKSER B, GRIDELLI B, TECTOR AJ, et al. Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit?[J]. Transplantation, 2009, 88(9): 1041-1049. DOI: 10.1097/TP.0b013e3181ba0555.
|
[8] |
PATEL MS, LOURAS N, VAGEFI PA. Liver xenotransplantation[J]. Curr Opin Organ Transplant, 2017, 22(6): 535-540. DOI: 10.1097/MOT.0000000000000459.
|
[9] |
CIMENO A, BARTH RN, LAMATTINA JC. Advances in liver xenotransplantation[J]. Curr Opin Organ Transplant, 2018, 23(6): 615-620. DOI: 10.1097/MOT.0000000000000578.
|
[10] |
RAMIREZ P, CHAVEZ R, MAJADO M, et al. The porcine liver supports metabolic homeostasis in the nonhuman primate: experimental study in a model of orthotopic liver transplantation from h-DAF transgenic pig to baboon[J]. Transplant Proc, 2000, 32(5): 1112-1113. DOI: 10.1016/s0041-1345(00)01150-7.
|
[11] |
EKSER B, LONG C, ECHEVERRI GJ, et al. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance[J]. Am J Transplant, 2010, 10(2): 273-285. DOI: 10.1111/j.1600-6143.2009.02945.x.
|
[12] |
KIM K, SCHUETZ C, ELIAS N, et al. Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons[J]. Xenotransplantation, 2012, 19(4): 256-264. DOI: 10.1111/j.1399-3089.2012.00717.x.
|
[13] |
DOU K, WANG D, TAO K, et al. A modified heterotopic auxiliary living donor liver transplantation: report of a case[J]. Ann Hepatol, 2014, 13(3): 399-403. DOI: 10.1016/S1665-2681(19)30872-5
|
[14] |
YEH H, MACHAIDZE Z, WAMALA I, et al. Increased transfusion-free survival following auxiliary pig liver xenotransplantation[J]. Xenotransplantation, 2014, 21(5): 454-464. DOI: 10.1111/xen.12111.
|
[15] |
NAVARRO-ALVAREZ N, SHAH JA, ZHU A, et al. The effects of exogenous administration of human coagulation factors following pig-to-baboon liver xenotransplantation[J]. Am J Transplant, 2016, 16(6): 1715-1725. DOI: 10.1111/ajt.13647.
|
[16] |
SHAH JA, NAVARRO-ALVAREZ N, DEFAZIO M, et al. A bridge to somewhere: 25-day survival after pig-to-baboon liver xenotransplantation[J]. Ann Surg, 2016, 263(6): 1069-1071. DOI: 10.1097/SLA.0000000000001659.
|
[17] |
SHAH JA, PATEL MS, ELIAS N, et al. Prolonged survival following pig-to-primate liver xenotransplantation utilizing exogenous coagulation factors and costimulation blockade[J]. Am J Transplant, 2017, 17(8): 2178-2185. DOI: 10.1111/ajt.14341.
|
[18] |
LI X, WANG Y, YANG H, et al. Liver and hepatocyte transplantation: what can pigs contribute?[J]. Front Immunol, 2021, 12: 802692. DOI: 10.3389/fimmu.2021.802692.
|
[19] |
YANG YG, SYKES M. Xenotransplantation: current status and a perspective on the future[J]. Nat Rev Immunol, 2007, 7(7): 519-531. DOI: 10.1038/nri2099.
|
[20] |
ZHOU Q, LI T, WANG K, et al. Current status of xenotransplantation research and the strategies for preventing xenograft rejection[J]. Front Immunol, 2022, 13: 928173. DOI: 10.3389/fimmu.2022.928173.
|
[21] |
EKSER B, KLEIN E, HE J, et al. Genetically-engineered pig-to-baboon liver xenotransplantation: histopathology of xenografts and native organs[J]. PLoS One, 2012, 7(1): e29720. DOI: 10.1371/journal.pone.0029720.
|
[22] |
COOPER D, EKSER B, TECTOR AJ. Immunobiological barriers to xenotransplantation[J]. Int J Surg, 2015, 23(Pt B): 211-216. DOI: 10.1016/j.ijsu.2015.06.068.
|
[23] |
CHEN G, QIAN H, STARZL T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys[J]. Nat Med, 2005, 11(12): 1295-1298. DOI: 10.1038/nm1330.
|
[24] |
ZHU A, HURST R. Anti-N-glycolylneuraminic acid antibodies identified in healthy human serum[J]. Xenotransplantation, 2002, 9(6): 376-381. DOI: 10.1034/j.1399-3089.2002.02138.x.
|
[25] |
COOPER DK. Modifying the sugar icing on the transplantation cake[J]. Glycobiology, 2016, 26(6): 571-581. DOI: 10.1093/glycob/cww028.
|
[26] |
WANG RG, RUAN M, ZHANG RJ, et al. Antigenicity of tissues and organs from GGTA1/CMAH/β4GalNT2 triple gene knockout pigs[J]. J Biomed Res, 2018. DOI: 10.7555/JBR.32.20180018.[Online ahead of print]
|
[27] |
Humoral reactivity of renal transplant-waitlisted patients to cells from ggta1/cmah/b4galnt2, and sla class i knockout pigs: erratum[J]. Transplantation, 2018, 102(2): e88. DOI: 10.1097/TP.0000000000002066.
|
[28] |
LADOWSKI JM, HARA H, COOPER D. The role of slas in xenotransplantation[J]. Transplantation, 2021, 105(2): 300-307. DOI: 10.1097/TP.0000000000003303.
|
[29] |
EKSER B, BURLAK C, WALDMAN JP, et al. Immunobiology of liver xenotransplantation[J]. Expert Rev Clin Immunol, 2012, 8(7): 621-634. DOI: 10.1586/eci.12.56.
|
[30] |
CANDINAS D, BELLIVEAU S, KOYAMADA N, et al. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection[J]. Transplantation, 1996, 62(12): 1920-1927. DOI: 10.1097/00007890-199612270-00042.
|
[31] |
FOX A, MOUNTFORD J, BRAAKHUIS A, et al. Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection[J]. J Immunol, 2001, 166(3): 2133-2140. DOI: 10.4049/jimmunol.166.3.2133.
|
[32] |
HAUZENBERGER E, KLOMINEK J, HOLGERSSON J. Anti-Gal IgG potentiates natural killer cell migration across porcine endothelium via endothelial cell activation and increased natural killer cell motility triggered by CD16 cross-linking[J]. Eur J Immunol, 2004, 34(4): 1154-1163. DOI: 10.1002/eji.200324568.
|
[33] |
LI S, YAN Y, LIN Y, et al. Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells[J]. Blood, 2007, 110(12): 3926-3935. DOI: 10.1182/blood-2007-01-065482.
|
[34] |
EZZELARAB M, GARCIA B, AZIMZADEH A, et al. The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients[J]. Transplantation, 2009, 87(6): 805-812. DOI: 10.1097/TP.0b013e318199c34f.
|
[35] |
AL-MOHANNA FA, COLLISON KS, ALLEN SP, et al. Naive neutrophils and xenotransplantation[J]. Lancet, 1996, 348(9036): 1246. DOI: 10.1016/S0140-6736(05)65524-9.
|
[36] |
ZHANG X, WANG Q, ZHAO J, et al. The resurgent landscape of xenotransplantation of pig organs in nonhuman primates[J]. Sci China Life Sci, 2021, 64(5): 697-708. DOI: 10.1007/s11427-019-1806-2.
|
[37] |
RAMIREZ P, MONTOYA MJ, RIOS A, et al. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase)[J]. Transplant Proc, 2005, 37(9): 4103-4106. DOI: 10.1016/j.transproceed.2005.09.186.
|